Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04220983 · ClinicalTrials.gov registry record · NA
PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT04220983 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 22 participants.
The verdict
NCT04220983, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Patients with metastatic prostate cancer can undergo MRI-guided prostate Stereotactic body radiation therapy (SBRT) without significant adverse events, similar to what has been reported for patients with localized prostate cancer. We hypothesize that prostate SBRT will be well-tolerated in metastatic prostate cancer patients, with quality of life outcomes similar to what has been reported in non-metastatic prostate cancer patients.
Interventions
- RADIATION MR-Guided Prostate SBRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2020-01-27 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04220983
The ClinicalTrials.gov registry entry for NCT04220983 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MR-Guided Prostate SBRT is the first listed.
NCT04220983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04220983 about?
NCT04220983 is a clinical study titled "PRAGMA (Prostate Radio Ablation Guided by Magnetic Resonance Imaging Acquisition) in Metastatic Prostate Cancer". Patients with metastatic prostate cancer can undergo MRI-guided prostate Stereotactic body radiation therapy (SBRT) without significant adverse events, similar to what has been reported for patients with localized prostate cancer. We hypothesize that prostate SBRT will be well-tolerated in metastati...
What is the current status of trial NCT04220983?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-01-27. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT04220983?
The interventions under investigation include: MR-Guided Prostate SBRT (RADIATION).
Who is sponsoring clinical trial NCT04220983?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.